Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Elsevier Joins Forces with Pharmaceutical Industry Leaders to Build New Drug–Drug Interaction Risk Calculator

    Sep 11, 2019, 11:25 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Sep 11, 2019 - Elsevier, the global information analytics business specializing in science and health, is working together with a set of evaluation partners that include industry leaders such as Boehringer Ingelheim, Eli Lilly and Company, Pierre Fabre, Sanofi, Servier, and others to develop a new and improved drug–drug interaction risk calculator (DDIRC)
    Full story
  • Life Image Announces New Value-Added Solution that Further Enhances the Google Cloud Healthcare API to De-Identify Patient Information in Medical Imaging Data

    Sep 10, 2019, 13:02 PM by Michael Croft
    NEWTON, MA - Sep 10, 2019 - Life Image, one of the world's largest global networks for sharing clinical and imaging data that is powered by leading interoperability standards, today announced the launch of a new enhancement and validation service that optimizes the de-identification functionality of the Google Cloud Healthcare API, which helps to power healthcare insights for security and compliance-focused environments
    Full story
  • Spring Bank Annouces $20 Million Strategic Debt Financing Agreement with Pontifax Medison Finance

    Sep 10, 2019, 10:09 AM by Michael Croft
    HOPKINTON, MA, UNITED STATES - Sep 4, 2019 - Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, inflammatory diseases and certain cancers, today announced that it has entered into a $20 million convertible debt financing agreement with Pontifax Medison Finance, a healthcare-dedicated venture debt fund
    Full story
  • FDA Extends CRADA with CluePoints to Further Explore a Data-Driven Approach to Quality Oversight in Clinical Trials

    Sep 10, 2019, 09:13 AM by Michael Croft
    KING OF PRUSSIA, US - Sep 10, 2019 - FDA and its stakeholders have an interest in assuring the integrity of clinical trial data and the protection of participants during the conduct of clinical research
    Full story
  • Donald A. Deieso, PhD: One of PharmaVOICE’s 100 Most Inspiring Leaders of 2019

    Sep 10, 2019, 08:23 AM by Michael Croft
    PRINCETON, NJ - Sep 10, 2019 - The WIRB-Copernicus Group® (WCG™) announced that its Executive Chairman and Chief Executive Officer (CEO), Donald A
    Full story
  • Optimizing Storage to Address Workflow Challenges in Biotech and Life Sciences Applications

    Sep 9, 2019, 17:35 PM by Michael Croft
    Bio-IT World  Digital transformation is no longer just a buzzword: it is an inescapable truth for many industries, including life sciences, and data storage is at the heart of this digital revolution.
    Full story
  • PureWeld XL tubing stands up to technical challenges of continuous bioprocessing

    Sep 9, 2019, 05:18 AM by Michael Croft
    FALMOUTH, UK - Sep 3, 2019 - A recent study from Watson-Marlow Fluid Technology Group (WMFTG), demonstrates that PureWeld® XL tubing offers extended lifespan and steady flow consistency when compared to other leading brands
    Full story
  • Watson-Marlow Fluid Technology Group’s Flexicon PF7 pump technology shortlisted for PPMA Group Industry Awards

    Sep 9, 2019, 05:15 AM by Michael Croft
    FALMOUTH, UK - Sep 9, 2019 - The world leader in niche peristaltic and sinusoidal pumps and fluid path technologies,Watson-Marlow Fluid Technology Group,will present highlights from its broad range of positive displacement pumps and liquid filling technologies at the 2019 PPMA Total Show, exhibition stand D-90, including the Flexicon PF7,shortlisted for the PPMA Group Industry Awards
    Full story
  • Creative Enzymes Has Launched Three Enzymes Products to Accelerate the Enzymes Research

    Sep 9, 2019, 05:09 AM by Michael Croft
    NEW YORK, NY, UNITED STATES - Sep 9, 2019 - As an excellent supplier and manufacturer, Creative Enzymes has recently launched three enzymes products, including protease, lipase and amylase products for researchers to accelerate your enzymes research process
    Full story
  • Rho Presenting on the Importance of Early Patient Involvement in Clinical Trial Design at OCT Texas

    Sep 6, 2019, 15:00 PM by Michael Croft
    DURHAM - Sep 9, 2019 - MEDIA ADVISORYRho Presenting on the Importance of Early Patient Involvement inClinical Trial Design at OCT Texas WHAT:                 Rho, a full-service contract research organization (CRO), is showcasing its nearly 35-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) Texas 2019 Conference, the newest addition to the Outsourcing in Clinical Trials series, taking place September 11-12 in Houston
    Full story
  • Big Data Biobanks Aren't Equally Open To Researchers

    Sep 6, 2019, 13:22 PM by Michael Croft
    NPR.org | Medical and genetic data from more than a million Americans are now in scientific databases. Some programs hoard the data, while others share widely with scientists, hoping to speed medical discovery.
    Full story
  • Worcestershire Health and Care NHS Trust Partners with Clinithink

    Sep 6, 2019, 10:06 AM by Michael Croft
    LONDON, UNITED KINGDOM - Sep 6, 2019 -  Clinithink’s CLiX ENRICH solution is now being used by the Worcestershire Health and Care NHS Trust, a Global Digital Exemplar Trust (GDE) internationally recognised for delivering improvements in the quality of care through the world-class use of digital technologies and information
    Full story
  • Physician Support Organization Health Plus Management Expands Support for Five Additional Practices in New York and New Jersey

    Sep 6, 2019, 08:49 AM by Michael Croft
    BROOKLYN, NY - Sep 5, 2019 - UNIONDALE, N.Y., SEPTEMBER 05, 2019 – Health Plus Management, a physician support organization (PSO) providing business management and operations services for independent physician practices specializing in musculoskeletal care, today announced the addition of five facilities to its rapidly expanding network of practices under management
    Full story
  • SEKISUI XenoTech Announces Expanded Consulting Opportunities Available to Clients

    Sep 5, 2019, 09:58 AM by Michael Croft
    KANSAS CITY, KS, UNITED STATES - Sep 5, 2019 - SEKISUI XenoTech now provides the opportunity for clients to work with top-tier consultants to analyze critical components of absorption, distribution, metabolism, and excretion (ADME) of their drug candidate to optimize the data package for regulatory submission
    Full story
  • Cala Health Names Veteran Leader Renee Ryan as Chief Executive Officer

    Sep 4, 2019, 10:48 AM by Michael Croft
    BURLINGAME, CA, UNITED STATES - Sep 4, 2019 - Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today announced that it has named Renee Ryan as Chief Executive Officer (CEO)
    Full story
  • Evidence-Based Variant Interpretation For The Modern Era

    Sep 4, 2019, 07:40 AM by Michael Croft

    Bio-IT World | Next Generation Sequencing has ushered in a new era of high-throughput genomic analysis and increased our ability to understand the molecular basis behind disease. While the capacity for generating genetic data has exploded, the capacity to interpret the meaning of this data has lagged. It was these issues that led the team at Genomenon to create Mastermind and, more recently, Mastermind Reporter.

    Full story
  • Creative Enzymes Has Broadened Its Product list to Accelerate Enzymes-related Projects

    Sep 4, 2019, 05:55 AM by Michael Croft
    SHIRLEY, NY, US - Sep 4, 2019 - As an excellent supplier and manufacturer, Creative Enzymes announced that they have broadened their enzyme product list in order to fully accelerate enzymes related projects
    Full story
  • Life Image Announces Launch of Real World Imaging™ (RWI™) to Improve Effectiveness of Real World Evidence Programs for Life Sciences and Artificial Intelligence-Led Innovation

    Sep 3, 2019, 14:18 PM by Michael Croft
    NEWTON, MA - Sep 3, 2019 - Life Image, the world’s largest medical evidence network for clinical and imaging data, today announced the launch of its new Real World Imaging (RWI™) offering to respond to researcher needs for maturing insights and accelerating drug development decisions
    Full story
  • BINDING SITE FEATURES BIOLOGICAL MATERIALS FOR TORCH TESTING APPLICATIONS

    Sep 3, 2019, 10:50 AM by Michael Croft
    SAN DIEGO, CA - Sep 3, 2019 -      As a leading manufacturer and supplier of products and services to both IVD manufacturers and researchers within the clinical, biopharmaceutical, and life sciences markets, BINDING SITE'sIMMUNOLOGICALS GROUP fully understands the necessity of sourcing high-quality biological materials for your various applications
    Full story
  • Bora secures FDA approval for CDMO services

    Sep 3, 2019, 08:32 AM by Michael Croft
    ZHUNAN, TAIWAN - Sep 3, 2019 - Bora, a contract development and manufacturing organization (CDMO) that specializes in modified release (MR) and solvent production, has reported a successful FDA general inspection for its facility in Zhunan, Taiwan
    Full story
  • «
  • 221
  • 222
  • 223
  • 224
  • 225
  • 226
  • 227
  • 228 (current)
  • 229
  • 230
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy